Manufacturing guide
Tablet Manufacturing MOQ, Cost and Lead Time
Tablet commercial planning must connect blend batch, tablet count, tooling, process route, coating, testing and packaging rather than relying on one headline MOQ.
Short answer
Tablet MOQ, cost and lead time are outputs of a defined manufacturing system: formula, tablet weight, process route, tooling, coating, test plan, package and target market. An uncomplicated direct-compression tablet using available tooling has a different commercial path from a granulated, coated tablet requiring custom punches and new methods.
Do not compare quotations until every supplier is pricing the same scope.
Evidence guide: Published evidence — supported by the linked technical source. · Development guidance — a practical decision or testing framework, not a universal specification. · Manufacturer-specific — depends on the selected site, equipment and commercial arrangement. · Product-specific validation — must be demonstrated with the actual formula, process, pack and market.
Convert packs into tablets and blend
Finished packs × tablets per pack = theoretical tablets required
Theoretical tablets × target tablet weight = theoretical compression blend
Illustrative example — not a quotation: 10,000 packs × 30 tablets at 800 mg per tablet equals 300,000 tablets and 240 kg theoretical blend before process allowance, sampling and rejects. A two-tablet daily serving changes consumer-days, but not tablets per pack unless pack architecture also changes.
Process route changes economics
Direct compression can use fewer unit operations when materials flow and compact adequately. Dry or wet granulation adds equipment time, handling and controls; wet granulation also introduces liquid addition and drying. Coating adds coating material, pan time, yield considerations and release checks.
Process selection must follow formulation behaviour, as explained in the manufacturing process guide, not a desire to minimize line items.
Tooling and setup
Existing round tooling may avoid a custom procurement step. A branded shape, score, embossing or unusual size can require tooling review or purchase. Tooling affects tablet geometry, compression behaviour, visual identity and schedule.
Setup and changeover economics also matter. A press may technically make a small quantity while cleaning, setup, testing and packaging make that run commercially inefficient.
Cost and MOQ stack
| Layer | Typical decision |
|---|---|
| Formula development | Is the product ready for scale or still experimental? |
| Raw materials | Which supplier quantities and specifications are binding? |
| Batch | What is the validated operating range of blender/granulator/press? |
| Tooling | Existing or custom punches and dies? |
| Coating | Functional, protective or visual; and at what weight gain/process? |
| Testing | Raw material, in-process, finished product and stability scope |
| Packaging | Bottle/blister components, print, tooling and line minimums |
The general cost guide helps normalize these layers.
Schedule dependencies
Development, ingredient qualification, tooling, packaging artwork and procurement can run partly in parallel, but commercial manufacture should not begin on unresolved specifications. Production-slot availability, granulation and drying time, coating, testing and release all affect the schedule.
Ask for a milestone plan with dependencies and owner, not one undifferentiated lead-time promise.
Quotation checklist
Confirm MOQ unit, planned tablet and pack output, formula and assay basis, process route, tooling ownership, coating, test scope, stability, packaging, artwork, yield treatment, surplus materials, release timeline, freight and re-order conditions. Use the supplement MOQ guide to identify the actual binding minimum.
Sources and evidence boundaries
- U.S. Food and Drug Administration, “Current Good Manufacturing Practices for Food and Dietary Supplements.” Official guidance
- ICH, “Q8(R2): Pharmaceutical Development.” Official guideline
- ICH, “Q1A(R2): Stability Testing of New Drug Substances and Products.” Official guideline
The equations are transparent planning examples. No universal tablet price, MOQ, yield or lead time is asserted.